This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
milla1cf Wed, 05/15/2024 - 19:05 May 15, 2024 — CardioFocus, Inc. , a medical device company dedicated to advancing ablation treatment for cardiac arrythmias, announced its participation at the HeartRhythm2024 conference, taking place in person at the Boston Convention & Exhibition Center and virtually, May 16-19, 2024.
milla1cf Thu, 01/18/2024 - 14:21 January 18, 2024 — Abbott announced the first global procedures have been conducted using the company's new Volt Pulsed Field Ablation (PFA) System to treat patients battling common abnormal heartrhythms such as atrial fibrillation (AFib).
Based on continuous monitoring of early recurrence of atrial tachyarrhythmia immediately after patients have undergone atrial fibrillation ablation, Musat et al. Early recurrence of atrial tachyarrhythmia (ERAT) is commonly seen following catheter ablation of AF, with reported incidences of up to 61% in the first three months.
milla1cf Tue, 06/11/2024 - 18:09 June 11, 2024 — Stereotaxis (NYSE: STXS), a pioneer in surgical robotics for minimally invasive endovascular intervention, today announced that Hospital Santa Maria della Pietà, in Nola in the Metropolitan City of Naples, has established the first robotic cardiac heart program in Southern Italy.
At this year’s HeartRhythm Society (HRS) conference in Boston in May, innovation, again, was the focus. PFA on Display As you walked into the expo hall, it was hard to miss the large space-age light displays of the Farapulse Pulsed Field Ablation system from Boston Scientific and the PulseSelect PFA system from Medtronic.
Getty Images milla1cf Tue, 02/06/2024 - 20:36 February 6, 2024 — Cortex announced the initiation of its RESOLVE-AF trial ( NCT05883631 ), a study formally launched in late October 2023. AFib is the most common heartrhythm disorder, affecting more than 30 million patients worldwide.
Food and Drug Administration (FDA), has granted approval to Boston Scientific for its FARAPULSE Pulsed Field Ablation System. intermittent) atrial fibrillation (AF) and is a unique new alternative to standard-of-care thermal ablation treatment. said Nick Spadea-Anello, president, Electrophysiology, Boston Scientific.
milla1cf Fri, 02/02/2024 - 17:02 February 2, 2024 — Biosense Webster, Inc. , Titled "Real-world Data Affirms Safety and Effectiveness of Low/Zero Fluoroscopy Atrial Fibrillation Ablation," the study was presented as a late-breaker at the 29th Annual International AF Symposium.
Outcomes of ablation with the FARAPULSE PFA System – a nonthermal treatment in which electric fields selectively ablateheart tissue – will be compared to outcomes following use of anti-arrhythmic drug (AAD) therapy, which is commonly prescribed for patients living with persistent AF. The company now anticipates U.S.
milla1cf Thu, 05/30/2024 - 10:31 May 30, 2024 — Stereotaxis , a pioneer in surgical robotics for minimally invasive endovascular intervention, announced the successful treatment of the first heartrhythm patients by Penn Presbyterian Medical Center (PPMC) utilizing the advanced Genesis Robotic Magnetic Navigation System.
milla1cf Tue, 05/21/2024 - 08:00 May 21, 2024 — Stereotaxis , a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it has been invited to present at HRS Africa Summit 2024 , scheduled to take place during HeartRhythm Society Scientific Sessions in Boston, Massachusetts.
Weight Loss Drug Linked with Reduced Need for Diuretics in Heart Failure Patients 7. Late-breaking Clinical Trial Results from FARADISE, admIRE Study and Advent Trial at HeartRhythm2024 Highlight Pulsed Field Ablation Developments for Atrial Fibrillation Treatment 8. Tenax Therapeutics Announces New U.S.
Pulsed-field energy ablation (PFA) was significantly associated with hemolysis compared to radiofrequency ablation (RFA) following pulmonary vein isolation (PVI), according to the results of a study presented at HeartRhythm2024.
International Stroke Conference 2024 to Present High-Profile Late-Breaking Science 6. Novel AI Platform Matches Cardiologists in Detecting Rheumatic Heart Disease 7. UH Harrington Heart and Vascular Institute First in World to Implant Penditure Clip Using Minimally Invasive Approach 10. In Memoriam: Bruce Wilkoff, MD, FHRS 5.
David passed away suddenly on February 10, 2024. He was a dear friend and colleague of the HeartRhythm Society and electrophysiologists around the world.
We hope everyone who attended HRS 2024 had a blast, and we hope all of you enjoy these top-six takeaways from electrophysiology’s biggest weekend of the year. The post Cardiac Wire’s Top Six Takeaways from HRS 2024 appeared first on Cardiac Wire.
milla1cf Wed, 06/19/2024 - 20:57 June 19, 2024 — When electrophysiologist Eugenio Cingolani, MD , isn’t seeing patients, he can usually be found in his laboratory, investigating improved treatments for heartrhythm disorders. Unfortunately, ablation also destroys healthy heart tissue in the process.
Simultaneously, thanks to the revolutionary work of cardiac electrophysiology (EP) physicians, scientists, and industry, ablative treatment of complex arrhythmias including AF has achieved ever-increasing efficacy and safety.
UC San Diego Health is the first in San Diego to successfully implant the world’s first dual chamber and leadless pacemaker system to help treat people with abnormal heartrhythms. UC San Diego Health implanted the pacemaker system in the first patient in February 2024. “To
Pulsed field ablation (PFA) was shown to be effective in treating patients with paroxysmal atrial fibrillation (AFib), with more patients free from atrial arrhythmias (AA) when compared with patients treated with thermal ablation, according to results from a secondary analysis of the ADVENT trial.
A catheter ablation procedure widely used to treat the most common heartrhythm disorder significantly reduces the burden of atrial fibrillation (AF) and results in clinically important improvements in symptoms and quality of life compared with a sham (placebo) procedure, according to late breaking research presented Sept.
will have AF, an irregular and potentially dangerous heartrhythm. AFHCUs included clinical actions such as ablation, cardioversion, initiation/intensification of rate or rhythm control medication, or progression to a pacemaker or implantable cardioverter-defibrillator. 2024, May 15). By 2030, approximately 12.2
In the article, “Pulsed field ablation prevents left atrial restrictive physiology after posterior wall isolation in patients with persistent atrial fibrillation” by Ariel Banai and colleagues, published in the August 2024 issue of HeartRhythm (21;8:1245-1247), the author Disclaimer information was incomplete.
Image courtesy: ACC christine.book Thu, 02/29/2024 - 11:22 February 29, 2024 — The American College of Cardiology ( ACC ) will soon be holding its ACC 73rd Annual Scientific Session & Expo , ACC.24 24 from April 6 - 8, 2024 in Atlanta, GA at the Georgia World Congress Center.
During its Annual Conference, HRS 2024, the HeartRhythm Society (HRS) announced findings from three new studies demonstrating the safety and efficacy of pulsed field ablation (PFA), a nonthermal ablation treatment for patients with atrial fibrillation (AF).
The patient was started on amiodarone, anticoagulation, and metoprolol, and scheduled for atrial flutter ablation. He underwent ablation in the EP Lab. Continue Eliquis 5mg BID, should be continued for 3 months == MY Comment , by K EN G RAUER, MD ( 9/18 /2024 ): == I found the following aspects of today's case of special interest.
An international consensus statement on how to treat atrial fibrillation with catheter or surgical ablation has been published in EP Europace, a journal of the European Society of Cardiology (ESC), and was recently presented at EHRA 2024, a scientific congress held April 7-9 in Berlin, Germany.
Image courtesy: Getty Images christine.book Wed, 07/24/2024 - 09:00 July 24, 2024 — Volta Medical , a health technology company developing artificial intelligence (AI) solutions to assist electrophysiologists, has announced a Joint Development Agreement with GE HealthCare. The company has obtained U.S.
milla1cf Thu, 03/28/2024 - 07:28 March 28, 2024 — Biosense Webster, Inc., patients, were presented as a late-breaker at the 2024 AF Symposium. 1 Among 20 patients who completed the 12-month follow-up visit, 100% achieved acute success from ablation procedures and 80% remained free from atrial arrhythmia recurrence at one year.
Launching the first FDA -approved PFA technology is not just a milestone; the PulseSelect PFA system is setting a new standard in safety for AF ablation with excellent efficacy and efficiency 1. In my clinical experience with the catheter, it was designed for AF ablation procedures.
milla1cf Tue, 03/05/2024 - 12:02 March 5, 2024 — Biosense Webster, Inc. , Most importantly, the recent published data on the VARIPULSE Platform demonstrates the safety using pulsed field ablation for patients being treated for AF." iii] The study reported a low fluoroscopy time of 7.8
tim.hodson Mon, 10/21/2024 - 11:24 Oct. 18, 2024 — The HeartRhythm Society (HRS) Board of Trustees unanimously approved the formation of HeartRhythm Advocates , a new, shared vision, cause-related nonprofit 501(c)(4) advocacy organization to complement the primary 501(c)(3) nonprofit structure of the HRS.
MANIFEST-17K provides confidence that, unlike conventional thermal ablation, PFA with the pentaspline catheter does not cause the most feared complication of AF ablation—esophageal damage—nor does it cause pulmonary vein stenosis or persistent injury to the diaphragm,” says senior author Vivek Reddy, MD , The Leona M. and Harry B.
Scott Rankin Associations Between Surgical Ablation and Operative Mortality After Mitral Valve Procedures The Annals of Thoracic Surgery June 2018 A. Chris Malaisrie Burden of preoperative atrial fibrillation in patients undergoing coronary artery bypass grafting The Journal of Thoracic and Cardiovascular Surgery June 2018 J.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content